BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18191586)

  • 1. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
    Yiannoutsos CT; Nakas CT; Navia BA;
    Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.
    Lee PL; Yiannoutsos CT; Ernst T; Chang L; Marra CM; Jarvik JG; Richards TL; Kwok EW; Kolson DL; Simpson D; Tang CY; Schifitto G; Ketonen LM; Meyerhoff DJ; Lenkinski RE; Gonzalez RG; Navia BA;
    J Magn Reson Imaging; 2003 Jun; 17(6):625-33. PubMed ID: 12766890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional patterns of brain metabolites in AIDS dementia complex.
    Yiannoutsos CT; Ernst T; Chang L; Lee PL; Richards T; Marra CM; Meyerhoff DJ; Jarvik JG; Kolson D; Schifitto G; Ellis RJ; Swindells S; Simpson DM; Miller EN; Gonzalez RG; Navia BA
    Neuroimage; 2004 Nov; 23(3):928-35. PubMed ID: 15528093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times.
    Laubenberger J; Häussinger D; Bayer S; Thielemann S; Schneider B; Mundinger A; Hennig J; Langer M
    Radiology; 1996 Jun; 199(3):805-10. PubMed ID: 8638009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.
    Fuller RA; Westmoreland SV; Ratai E; Greco JB; Kim JP; Lentz MR; He J; Sehgal PK; Masliah E; Halpern E; Lackner AA; González RG
    BMC Neurosci; 2004 Mar; 5():10. PubMed ID: 15070430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep gray matter structures in HIV infection: a proton MR spectroscopic study.
    Meyerhoff DJ; Weiner MW; Fein G
    AJNR Am J Neuroradiol; 1996 May; 17(5):973-8. PubMed ID: 8733976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
    Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
    Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.
    Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Orzechowska-Bobkiewicz A; Dzienis W; Prokopowicz D; Walecki J
    Med Sci Monit; 2004 Jun; 10 Suppl 3():101-6. PubMed ID: 16538209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.
    Simone IL; Federico F; Tortorella C; Andreula CF; Zimatore GB; Giannini P; Angarano G; Lucivero V; Picciola P; Carrara D; Bellacosa A; Livrea P
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):516-23. PubMed ID: 9576546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
    Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
    J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.
    Harezlak J; Cohen R; Gongvatana A; Taylor M; Buchthal S; Schifitto G; Zhong J; Daar ES; Alger JR; Brown M; Singer EJ; Campbell TB; McMahon D; So YT; Yiannoutsos CT; Navia BA;
    J Neurovirol; 2014 Jun; 20(3):294-303. PubMed ID: 24696364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
    Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
    Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
    Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
    Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.